Media Center

Read the press release
Milan – Italy, June 16, 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG
2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic data interpretation.
Read the press release


What they say
about Alamut

"Alamut is the best tool I have used for the annotation of DNA variants. It has a great user interface, combines data from multiple sources and allows for ease of variant interpretation by clinical geneticists."

JORDAN LERNER-ELLIS, Ph.D.
Mt. Sinai Hospital, Toronto

Events

16.10.2018

ASHG 2018

USA

16.06.2018

ESHG 2018

Italy